SS Innovations International Inc. (NASDAQ: SSII) has appointed veteran medtech finance executive Sarah M. Romano as chief financial officer, effective August 3, 2026. The appointment comes as the surgical robotics developer accelerates its global expansion and advances regulatory initiatives for its SSi Mantra robotic surgical platform.
Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised more than $100 million during her career. She previously served as CFO at Vicarious Surgical, another developer of robotic surgical technologies, where she oversaw financial and operational initiatives designed to reduce cash burn and strengthen the company's balance sheet.
The leadership addition coincides with SS Innovations' continued pursuit of U.S. Food and Drug Administration clearance for its SSi Mantra system. The company has been expanding internationally while preparing for the FDA review process. More details on the regulatory pathway can be found in the company's recent announcements (https://nnw.fm/yY4UM).
In addition to regulatory progress, SS Innovations recently graduated the inaugural class of its SS International Centre for Robotics Surgery (SSICRS) cardiac robotic surgery training program. The program welcomed 33 healthcare professionals from seven countries, highlighting the company's emphasis on surgeon education alongside technology deployment.
The dual focus on regulatory advancement and training infrastructure positions SS Innovations to address the growing demand for minimally invasive surgical options worldwide. The SSi Mantra system is designed to provide surgeons with enhanced precision and control during complex procedures, potentially improving patient outcomes and reducing recovery times.
Investors can follow the latest updates from SS Innovations in the company's newsroom (https://nnw.fm/SSII). The appointment of Romano, with her extensive capital markets experience, signals the company's preparation for potential financing needs as it scales its operations and prepares for potential U.S. market entry.
The global surgical robotics market is projected to grow significantly in the coming years, driven by technological advancements and increasing adoption of robotic-assisted surgeries. SS Innovations aims to capture market share with its SSi Mantra system, which has already received regulatory approvals in several international markets.
